GlobeNewswire by notified

OR 2022 Consolidated Annual Financial Statements - Solid operations and finances

Share

Reykjavík Energy Group’s (Orkuveita Reykjavíkur; OR) operations are on a solid course and operating results are good while assets are growing rapidly. At the same time tariffs for licensed services have fallen in real terms. The Group’s financial status, according to the 2022 Annual Financial statements, enables the company to support the necessary sustainable projects Icelandic society needs in the coming years.

In addition to the parent company, the Reykjavík Energy Group comprises Veitur Utilities, ON Power, Reykjavík Fibre Network, and Carbfix. Reykjavík Energy’s consolidated annual financial statements were approved by the Board of Directors with a profit of ISK 8,4 billion. The board proposes to the general meeting that a dividend of ISK 5.5 billion be paid. The owners of Reykjavík Energy are the City of Reykjavík, Akranes Township, and the Municipality of Borgarbyggð.

Weathers effects of inflation – so far
Inflation has a significant impact on OR Group’s operations, which are mostly denominated in ISK. It affects the operation when inflation increases dramatically after the period of low interest rates during the pandemic. Thus, expenses from interests and indexing of loans increased from ISK 8 billion in 2021 to ISK 13 billion last year. However, other factors beneficial to the operations made it possible to keep the increase in tariffs below inflation, which means a real term decrease for consumers. EBITDA ratio in 2022 was 62.7%, thus continually strong.

Reykjavík Energy 2022 Annual Report
Along with the annual financial statements, Reykjavík Energy publishes its integrated Annual Report for year 2022. The report provides a detailed account of the environmental aspects of the OR Group’s operations, social effects, and governance, as well as key financial metrics. The Group’s carbon footprint grew between the years 2021 and 2022, but will shrink significantly in the coming years with increased carbon capturing from ON Power’s geothermal power plants.
The annual report is audited by independent parties and signed by the CEO and the board. It can be retrieved at annualreport2022.or.is.

Also today, Reykjavík Energy publishes its Green Finance Impact Report 2022. It is audited by OR’s certified auditor, Grant Thornton, and defines the allocation of money OR has borrowed under the company's green financing framework.
Also, Reykjavík Energy publishes today its At the same time, the Impact Report of OR's green financing is published. It is signed by OR's certified auditors, Grant Thornton, and describes the use of the funds that OR has borrowed within the company's green financing framework.

Bjarni Bjarnason, CEO
It is good to retire from the company in a such a good and healthy state. Reykjavík Energy’s finances have never been stronger and valuably so. Ahead lie large and urgent projects. The fight against the climate crisis is critical, as is adaptation to the consequences of climate change. Reykjavík Energy’s goal of carbon neutrality is vital, and we must place the group’s weight on the scales of the circular economy. The leadership of the companies within the OR Group in energy shifts undisputed and will continue to have a significant impact on how the nation succeeds.
Over the past decade, there has been a gender equality revolution in the Icelandic energy and utility industry. I am proud of Reykjavík Energy’s role in these achievements, and I hope that the Group’s ambitious gender equality work will be an inspiration to the managers of other companies.

Overview of financial and non-financial figures
The table contains some significant sustainability aspects of Reykjavík Energy’s operations in recent years. A more detailed overview of these and other sustainability factors can be found in the integrated Reykjavík Energy Annual Report 2022.

20152016201720182019202020212022Unit
Operating revenues40,31241,42343,66645,91646,57048,62751,89056,965ISK mill.
Operating expenses-15,183-16,062-17,285-17,299-18,398-19,172-18,380-21,220ISK mill.
EBIT14,42814,96817,31818,34616,05116,39820,25321,306ISK mill.
EBITDA25,17425,36126,38028,61728,17229,45433,51035,745ISK mill.
EBITDA ratio62.4%61.2%60.4%62.3%60.5%60.6%64.6%62.7%Ratio
Gender pay-gap2.30%2.10%0.20%0.00%0.10%0.00%-0.20%0.10%Ratio
Job satisfaction4.34.44.44.44.34.44.34.3Grade 1-5
Hot water837894101101110106108mill.m3
Electricity3,2493,4113,4733,5073,5363,5813,5453,494GWh
Potable water2930292829262627mill.m3
Data via Ljósleiðarinn122,000155,000180,000216,000260,000345,000396,000443,000TB
Carbon footprint67,10045,45042,70045,45048,75050,55048,65051,080tn. CO2-eq.
Mineralized CO2        5,200         9,000       12,000       12,000       10,500       11,700       13,300       12,100 tonnes

Attached are:

  • OR Consolidated Financial Statements 2022 on pdf-format.
  • OR Green Finance Impact Report 2022
  • Zip-file containing OR Consolidated Financial Statements 2022 on ESEF-format.
  • XHTML-viewer file.


Contact:
Bjarni Bjarnason
CEO
+ 354 516 6100


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification6.5.2024 23:25:48 CEST | Press release

Global healthcare certification leader convenes experts to discuss ultrasound training and certification as key strategy to reduce maternal mortality ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, will host a roundtable discussion titled "Advancing Maternal and Fetal Health through POCUS Training and Certification" on May 29 alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit. The roundtable will explore the urgent need to expand point-of-care ultrasound (POCUS) training and certification for frontline maternal health clinicians as a crucial intervention for reducing preventable maternal deaths and achieving UN Sustainable Development Goals, and how to implement to scale. Despite the increased availability of affordable ultrasound technology, there remains a significant training gap that limits access to this diagnostic tool, especially in low-resource areas with high matern

ETC’s Commercial/Industrial Units Awarded Three Contracts Totaling $15.9 Million6.5.2024 22:15:00 CEST | Press release

SOUTHAMPTON, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Sterilization Systems Group announced it has been awarded $13.9 million in contracts from two multi-national medical device manufacturers. The contracts include four, sixteen pallet ethylene oxide (“EO”) sterilization system chambers with related conveyer systems, and a large capacity vacuum drying chamber with preconditioning. “These contracts reflect ETC Sterilization Systems Group’s dedication to innovation in our mechanical designs, control systems and software expertise to meet the challenging requirements of this market,” states Eric Hunnicutt, ETC Director of EO Sterilizer Sales. ETC’s Sterilization Systems Group offers Steam and Ethylene Oxide (“EO”) Sterilizer Systems, Vacuum Dryers, Software Systems, and project management services to the Medical Device, Pharmaceutical, Biotechnology, and Life Science industries. ETC’s systems are specially design

Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC6.5.2024 22:05:00 CEST | Press release

If approved, Zeno will be the first targeted therapy for NRG1+ cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Biologics License Application (BLA) for the bispecific antibody zenocutuzumab (Zeno) in patients with neuregulin 1 fusion (NRG1+) non-small cell lung (NSCLC) and NRG1+ pancreatic (PDAC) cancer. “FDA acceptance of our first BLA represents an important achievement for Merus and an important potential treatment opportunity for patients with NRG1+ cancer, a disease with poor prognosis and high unmet need,” said Dr. Andrew Joe, Chief Medical Officer at Merus. “Zenocutuzumab has the potential to be the first and only targeted therapy for patients with NRG1+ lung and

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

HiddenA line styled icon from Orion Icon Library.Eye